Pharmaceutical company in
Rotkreuz

Amgen Switzerland AG

Since 2005 · 21–50 empl.·3.5(6)

Amgen Switzerland AG is a biotechnology company that researches and develops biologic medicines and other therapies. In Switzerland, it markets prescription medicines for conditions including cancer, rare and chronic inflammatory diseases, and cardiovascular and bone disorders, and is active in clinical research.

Amgen (Europe) GmbH

Since 2005 · 11–20 empl.·3.5(6)

Amgen (Europe) GmbH is a biopharmaceutical company that develops, manufactures and commercializes biologic medicines, focusing on therapies for serious conditions including oncology, cardiology, bone health, chronic inflammatory and rare diseases.

Roche Diagnostics International AG

Since 1998 · 500+ empl.

Roche Diagnostics International AG develops and supplies diagnostic systems and tests for hospitals, laboratories and medical practices. The organization integrates research and development, production, marketing and service functions to create instruments, fully automated in‑vitro diagnostic systems and digital solutions.

Swiss Cardio Technologies AG

Since 2008 · 11–20 empl.

Swiss Cardio Technologies AG focuses on the development of Cardioplexol®, a cardioplegic solution for cardiovascular surgery. The company holds the product’s exclusive global licence.

NOBEL Pharma Schweiz AG

Since 2018 · 11–20 empl.

NOBEL Pharma Schweiz AG offers medicines across several therapeutic areas, including allergies, cardiovascular conditions, gastrointestinal disorders, the nervous system and pain management. The company aims to contribute to the security of medicine supply in Switzerland.

Medical Pharma Services, s.r.o., Prag, Zweigniederlassung Risch

Since 2019 · 21–50 empl.

Medical Pharma Services, s.r.o., Prag, Zweigniederlassung Risch provides Medical Affairs services under the name MphaR for pharmaceutical, biotechnology and healthcare organizations. Its services include medical strategy, scientific education, advisory boards, publication support and assistance with clinical trials.

Candoro ethics AG

Since 2023 · 1–10 empl.

Candoro ethics AG is part of the Dermapharm group. Its integration expanded the group’s capabilities in narcotic drugs in Switzerland.

Novartis Pharma Schweiz AG

Since 1986 · 101–500 empl.·1.0(1)

Novartis Pharma Schweiz AG is a pharmaceutical company that conducts research and development, manufactures and markets medicines, and provides information and services for patients and healthcare professionals.

Sandoz Pharmaceuticals AG

Since 2006 · 101–500 empl.·3.1(13)

Sandoz Pharmaceuticals AG is a pharmaceutical company focused on generics and biosimilars. Its portfolio includes prescription and over-the-counter medicines for a range of therapeutic areas.

Gynial AG

Since 2015 · 21–50 empl.·3.0(2)

Gynial AG is a pharmaceutical company focused on women’s health and gynaecology. It supplies contraceptives, as well as prescription and non-prescription medicines and medical products, including products for intimate and women’s health.

Sanofi International AG

Since 2025 · 1–10 empl.

Sanofi International AG operates in the pharmaceutical sector, offering therapeutic solutions, vaccines, medicines and health products. Its areas of activity include immunology, rare diseases, oncology, neurology, diabetes and cardiovascular diseases.

Polpharma Biologics International AG

Since 2025 · 1–10 empl.

Polpharma Biologics International AG develops and manufactures biosimilars and supports programs through to commercial supply. Its activities include process and formulation development, clinical development, regulatory and quality work, and post-approval lifecycle management.